YAPALI, S. Et Al. 2022. Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis. ınternational Liver congress ILC 2022 (EASL) .

YAPALI, S., GÖKCAN, H., DURAK, S., MELEKOĞLU ELLİK, Z., ADANIR, H., GÜNDÜZ, F. F., ... ÖZDİL, K.(2022). Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis . ınternational Liver congress ILC 2022 (EASL)

YAPALI, SUNA Et Al. "Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis," ınternational Liver congress ILC 2022 (EASL), 2022

YAPALI, SUNA Et Al. "Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis." ınternational Liver congress ILC 2022 (EASL) , 2022

YAPALI, S. Et Al. (2022) . "Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis." ınternational Liver congress ILC 2022 (EASL) .

@conferencepaper{conferencepaper, author={SUNA YAPALI Et Al. }, title={Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis}, congress name={ınternational Liver congress ILC 2022 (EASL)}, city={}, country={}, year={2022}}